Corrigendum to "Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction" Journal of Cardiac Failure, Vol. 22, No. 6, June 2016, pp. 423-432

Affiliations

• ¹ Department of Cardiology, Kameda Medical Center, Chiba, Japan. Electronic address: [email protected].
• ² Department of Cardiology, Kameda Medical Center, Chiba, Japan.
• ³ Department of Cardiology, Tokai University School of Medicine, Kanagawa, Japan.
• ⁴ Department of Cardiology, Tomishiro Central Hospital, Okinawa, Japan.
• ⁵ Department of Cardiology, Tokyo Metropolitan Hiroo Hospital, Tokyo, Japan.
• ⁶ Department of Cardiology, Ome Municipal General Hospital, Tokyo, Japan.
• ⁷ Department of Cardiology, Yokohama Minami Kyosai Hospital, Kanagawa, Japan.
• ⁸ Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
• ⁹ Department of Cardiology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
• ¹⁰ Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.
• ¹¹ Department of Cardiology, Hiratsuka Kyosai Hospital, Kanagawa, Japan.
• ¹² Department of Cardiology, Tokyo Yamate Medical Center, Tokyo, Japan.
• ¹³ Department of Cardiology, Sakakibara Heart Institute of Okayama, Okayama, Japan.
• ¹⁴ Department of Cardiology, National Disaster Medical Center, Tokyo, Japan.
• ¹⁵ Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
• ¹⁶ Division of Cardiology, Hennepin County Medical Center and University of Minnesota, Minneapolis, Minnesota.